Skip to main content
Amoy Diagnostics Co on Muck Rack

Amoy Diagnostics Co

As seen in: Yahoo Finance, Frontiers in Immunology, Diagnostic Pathology, GlobeNewswire
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Amoy Diagnostics

Contact Amoy Diagnostics, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Frontiers | A 7-gene expression signature predicts immune microenvironment remodeling and neoadjuvant chemo-immunotherapy response in lung squamous cell carcinoma

|
By Amoy Diagnostics Co
| Frontiers in Immunology
Abstract Background: Neoadjuvant chemo-immunotherapy (NCI) has significantly improved outcomes in advanced lung squamous cell carcinoma (LUSC). However, some patients remain resistant to NCI, resulting in poor outcomes. The mechanisms behind this resistance remain unclear. Methods: Forty LUSC patients receiving NCI were selected and categorized into major pathological response (MPR) and non-MPR groups based on their pathological response.
Open in Who Shared Issue with article?

Molecular subtyping of endometrial cancer via a simplified one-step NGS classifier, ARID1A and ZFHX4 mutations help further subclassify CNL/MSI-H patients | Diagnostic Pathology | Full Text

|
By Amoy Diagnostics Co, Chenggong Sun, Zhan Huang, Changbin Zhu, Aijun Yin, Qiuli Teng, Zeng Yuan, Yulong Mu, Shuaixin Wang, Linhan Chin, Ruifen Dong
| Diagnostic Pathology Verified
References Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. Cancer J Clin. 2016;66(2):115–32. Article Google Scholar Siegel RL, Miller KD, Wagle NS, Jemal A, Cancer statistics. 2023. CA: a cancer journal for clinicians. 2023;73(1):17–48. Murali R, Soslow RA, Weigelt B. Classification of endometrial carcinoma: more than two types. Lancet Oncol. 2014;15(7):e268–78. Article PubMed Google Scholar Barbari SR, Shcherbakova PV.
Open in Who Shared Issue with article?
|
By Amoy Diagnostics Co
| GlobeNewswire
SHANGHAI, Chine, 18 avr. 2022 (GLOBE NEWSWIRE) -- Amoy Diagnostics Co., Ltd (AmoyDx), une société de diagnostics moléculaires innovants basée en Chine (SZSE : 300685), annonce aujourd'hui la conclusion d'un accord-cadre de collaboration avec AstraZeneca (LSE/STO/Nasdaq : AZN), une société biopharmaceutique mondiale guidée par la science.
Open in Who Shared Issue with article?
See all 8 articles